Compared with cytogenetically normal AML, FLT3 mutant leukemias are characterized by a higher incidence of disease recurrence after conventional cytoreductive therapy, shorter time to relapse, and lower overall survival [38]. Here, FLT3 is linked to acute myeloid leukemia.